ISPOR TRANSLATING RESEARCH TO PRACTICE SPECIAL INTEREST GROUP (TRP) |
|
DISEASE MANAGEMENT WORKING GROUP |
| Chair: Renée J. G. Arnold,
President & CEO, Arnold Consultancy & Technology LLC, ACT!, New
York, NY, USA |
Goal: The goal of the Disease
Management Working Groups is to increase the awareness of the
importance and application of pharmacoeconomic and health
outcomes principles in the development and evaluation of disease
management programs used in a variety of health care practice
settings (including managed care organizations, group practices,
hospitals, Medicaid and Medicare populations and public health
entities) and the use of this evaluation information in health
care decisions.
Towards this goal, the Disease Management Working Group plans to
develop appropriate analytic principles, case examples, and
research relevant to practitioners in these settings.
|
| Key Tasks: |
Disease Management Program Development
- Identify key issues on the use of pharmacoeconomic and
outcomes research principles in the disease management program
development
- Determine how to address these issues on the disease
management program development
- Define good practices on disease management program
development
- Develop case examples on disease management program
development good practices
- Develop publications and/or presentations to promote good
practices on disease management program development with ISPOR
and other professional societies such as Disease Management
Association of America (DMAA)
|
|
|
